<DOC>
	<DOC>NCT01273545</DOC>
	<brief_summary>This study will use electronic health services databases to describe the usage patterns of dapoxetine hydrochloride (PRILIGY) in Germany and Italy with a focus on describing the extent and proportion of patients with characteristics suggestive of the use of PRILIGY within, versus outside of the intended use population.</brief_summary>
	<brief_title>PRILIGY Usage Patterns in Selected Populations</brief_title>
	<detailed_description>This study will use anonymized (nameless) patient data from electronic health services databases in Germany and Italy to describe the proportion of PRILIGY (dapoxetine hydrochloride) usage among those patients with characteristics suggestive of the use of PRILIGY within versus outside (eg, those with contraindications) of the intended use (IU) population. This is an observational study; no investigational drug will be administered.</detailed_description>
	<mesh_term>Sexual Dysfunction, Physiological</mesh_term>
	<criteria>Received a prescription for PRILIGY Treated by physicians who contributed data to the IMS Disease Analyzer database for Germany and Thales database for Italy Age not specified Sex not specified as "male " Fewer than 6 months (183 days) of history in the electronic health services databases before receiving the first prescription for PRILIGY (At least 6 months of history in the database is not required for the patients of the German urologists).</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Dapoxetine hydrochloride (PRILIGY)</keyword>
	<keyword>Premature ejaculation</keyword>
</DOC>